相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP
Eleanor M. Wigmore et al.
PHARMACOGENOMICS JOURNAL (2020)
Adult hippocampal neurogenesis and antidepressants effects
Barbara Planchez et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
A Genetic Investigation of the Well-Being Spectrum
B. M. L. Baselmans et al.
BEHAVIOR GENETICS (2019)
Polygenic Risk: Predicting Depression Outcomes in Clinical and Epidemiological Cohorts of Youths
Thorhildur Halldorsdottir et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Genome-wide association study identifies 30 loci associated with bipolar disorder
Eli A. Stahl et al.
NATURE GENETICS (2019)
PRSice-2: Polygenic Risk Score software for biobank-scale data
Shing Wan Choi et al.
GIGASCIENCE (2019)
A global overview of pleiotropy and genetic architecture in complex traits
Kyoko Watanabe et al.
NATURE GENETICS (2019)
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
A. Kautzky et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis
Jian-Ping Zhang et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology
Emily L. Belleau et al.
BIOLOGICAL PSYCHIATRY (2019)
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples
Chiara Fabbri et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Multivariate genome-wide analyses of the well-being spectrum
Bart M. L. Baselmans et al.
NATURE GENETICS (2019)
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation
R. N. Moda-Sava et al.
SCIENCE (2019)
Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
M. Dold et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample
Alexander Kautzky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
Naomi R. Wray et al.
NATURE GENETICS (2018)
Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways
David M. Howard et al.
NATURE COMMUNICATIONS (2018)
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
Azmeraw T. Amare et al.
FRONTIERS IN PSYCHIATRY (2018)
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
Amit V. Khera et al.
NATURE GENETICS (2018)
Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts
Joey Ward et al.
PLOS ONE (2018)
Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
Ida Seeberg et al.
FRONTIERS IN PSYCHIATRY (2018)
Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapy
Jerome C. Foo et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2018)
Pharmacogenetics of antidepressant response: A polygenic approach
Judit Garcia-Gonzalez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
Pradeep Natarajan et al.
CIRCULATION (2017)
Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial)
Iftikhar J. Kullo et al.
CIRCULATION (2016)
May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?
Massimiliano Buoli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses
Aysu Okbay et al.
NATURE GENETICS (2016)
Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review
Vera De Carlo et al.
PSYCHIATRY RESEARCH (2016)
Epigenetic differences in monozygotic twins discordant for major depressive disorder
K. Malki et al.
TRANSLATIONAL PSYCHIATRY (2016)
Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts
H. C. Whalley et al.
TRANSLATIONAL PSYCHIATRY (2016)
A Fast Method that Uses Polygenic Scores to Estimate the Variance Explained by Genome-wide Marker Panels and the Proportion of Variants Affecting a Trait
Luigi Palla et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression
Alexander Kautzky et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Paul E. Greenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach
A. B. Niculescu et al.
MOLECULAR PSYCHIATRY (2015)
Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder
Marleen H. M. de Moor et al.
JAMA PSYCHIATRY (2015)
Genetic Susceptibility for Bipolar Disorder and Response to Antidepressants in Major Depressive Disorder
Katherine E. Tansey et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996-2013
David A. Mrazek et al.
PSYCHIATRIC SERVICES (2014)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
Pharmacogenetics in major depression: A comprehensive meta-analysis
Tomihisa Niitsu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Power and Predictive Accuracy of Polygenic Risk Scores
Frank Dudbridge
PLOS GENETICS (2013)
Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development
Garret R. Anderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A practical approach to the early identification of antidepressant medication non-responders
J. Li et al.
PSYCHOLOGICAL MEDICINE (2012)
MaCH: Using Sequence and Genotype Data to Estimate Haplotypes and Unobserved Genotypes
Yun Li et al.
GENETIC EPIDEMIOLOGY (2010)
Genetic and Environmental Influences on Pro-Inflammatory Monocytes in Bipolar Disorder A Twin Study
Roos C. Padmos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Prediction of individual genetic risk of complex disease
Naomi R. Wray et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Prediction of individual genetic risk to disease from genome-wide association studies
Naomi R. Wray et al.
GENOME RESEARCH (2007)
Population structure and eigenanalysis
Nick Patterson et al.
PLOS GENETICS (2006)
The impact of treatment-resistant depression on health care utilization and costs
WH Crown et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
分享论文
